Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-06-05

Clinical Trial Update: Spironolactone for Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

This is a clinical trial update evaluating spironolactone for paroxysmal atrial fibrillation. The status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Atrial Fibrillation | NA | Status: UNKNOWN